Stay updated on Atogepant 60mg for Episodic Migraine: Safety Clinical Trial
Sign up to get notified when there's something new on the Atogepant 60mg for Episodic Migraine: Safety Clinical Trial page.

Latest updates to the Atogepant 60mg for Episodic Migraine: Safety Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedReferences has been added to the study history page. The revision label was updated to v3.6.4, indicating a new version of the record and tracking of changes.SummaryDifference0.3%

- Check21 days agoChange DetectedThe References section was removed from this version of the study record, so the cited sources are no longer displayed on the page.SummaryDifference0.2%

- Check28 days agoNo Change Detected
- Check36 days agoChange DetectedThe study history gains a new revision entry for v3.6.3 and a References section is added; the previous revision entry v3.6.2 is removed from the list.SummaryDifference0.3%

- Check43 days agoChange DetectedThe record history now shows Revision: v3.6.2, indicating a recent site version update that changes the footer revision label from the previous v3.6.0.SummaryDifference0.1%

- Check57 days agoChange DetectedThe record history shows that enrollment has ended for this study, with the recruitment status updated accordingly. A new revision tag v3.6.0 was added and the previous revision v3.5.5 was removed from the history.SummaryDifference0.4%

- Check64 days agoChange DetectedA new revision entry 'Revision: v3.5.5' was added to the history. The 'Revision: v3.5.4' entry and its References were removed, reflecting administrative updates to the page's revision history.SummaryDifference0.3%

Stay in the know with updates to Atogepant 60mg for Episodic Migraine: Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atogepant 60mg for Episodic Migraine: Safety Clinical Trial page.